Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

THEOPHYLLINE 4MG AND 5% DEXTROSE INJ 4 MG — DIN 00828742

THEOPHYLLINE : 4 MG DEXTROSE : 50 MG · BAXTER CORPORATION · SOLUTION · wholesale supply in Canada

Health Canada status: CANCELLED POST MARKET

What is THEOPHYLLINE 4MG AND 5% DEXTROSE INJ?

THEOPHYLLINE 4MG AND 5% DEXTROSE INJ 4 MG contains THEOPHYLLINE : 4 MG DEXTROSE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00828742, held by BAXTER CORPORATION, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 29-Jul-2005. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.

Is there a generic Theophylline, Combinations Excl. Psycholeptics in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

8 holders have a Canadian DIN containing Theophylline, Combinations Excl. Psycholeptics, across 12 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
SEARCHLIGHT PHARMA INC11CHOLEDYL EXPECTORANTSourceable in Canada
BAXTER CORPORATION30THEOPHYLLINE 0.8MG AND 5% DEXTROSE INJ, THEOPHYLLINE 1.6MG AND 5% DEXTROSE INJ, THEOPHYLLINE 4MG AND 5% DEXTROSE INJNo marketed DIN
ROUGIER PHARMA DIVISION OF RATIOPHARM INC30I D M EXPECTORANT TAB, IDM TAB, THEOPHYLLINE ROUGIER ELIXIRNo marketed DIN
CARMARAN LTÉE10BRONCHYL SYRNo marketed DIN
HOSPIRA HEALTHCARE ULC10THEOPHYLLINE 0.8MG/ML IN 5% DEXTROSE INJNo marketed DIN
LES LABORATOIRES BIO-SANTÉ INC.10PULMO SEPTOL SIROPNo marketed DIN
PHARMASCIENCE INC10PMS-OXTRIPHYLLINE ELIXIRNo marketed DIN
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED10RATIO-THEO-BRONCNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label4 MG
Dosage formSOLUTION
RouteINTRAVENOUS

Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.

Substance and classification

Active substanceTheophylline, Combinations Excl. Psycholeptics
ATC codeR03DA54
AHFS class86:16.00
Biosimilar biologicNo

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)00828742
DIN (unpadded, as printed on some documents)828742
Brand nameTHEOPHYLLINE 4MG AND 5% DEXTROSE INJ
Generic / active ingredientTHEOPHYLLINE : 4 MG DEXTROSE : 50 MG
Market authorization holderBAXTER CORPORATION
Health Canada schedulePrescription
ATC codeR03DA54
ATC anatomical main groupR — Respiratory system
ATC therapeutic subgroupR03DA
Current statusCANCELLED POST MARKET
Status date29-Jul-2005
Original market date1995-12-31 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

1 of 12 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
CHOLEDYL EXPECTORANT50 MG / 5 MLSOLUTIONSEARCHLIGHT PHARMA INCMARKETED00476374
BRONCHYL SYR500 MG / 10 MLLIQUIDCARMARAN LTÉECANCELLED POST MARKET00545090
I D M EXPECTORANT TAB12 MGTABLETROUGIER PHARMA DIVISION OF RATIOPHARM INCCANCELLED POST MARKET00334510
IDM TAB140 MGTABLETROUGIER PHARMA DIVISION OF RATIOPHARM INCCANCELLED POST MARKET00356123
PMS-OXTRIPHYLLINE ELIXIR20 MGELIXIRPHARMASCIENCE INCCANCELLED POST MARKET00792942
PULMO SEPTOL SIROP.06 MGSYRUPLES LABORATOIRES BIO-SANTÉ INC.CANCELLED POST MARKET00721301
RATIO-THEO-BRONC16 MGSYRUPRATIOPHARM INC DIVISION OF TEVA CANADA LIMITEDCANCELLED POST MARKET00317225
THEOPHYLLINE 0.8MG AND 5% DEXTROSE INJ.8 MGSOLUTIONBAXTER CORPORATIONCANCELLED POST MARKET00828718
THEOPHYLLINE 0.8MG/ML IN 5% DEXTROSE INJ5.0 %SOLUTIONHOSPIRA HEALTHCARE ULCCANCELLED POST MARKET00640093
THEOPHYLLINE 1.6MG AND 5% DEXTROSE INJ50 MGSOLUTIONBAXTER CORPORATIONCANCELLED POST MARKET00828726

2 · Same class — other molecules in ATC R03DA

MoleculeCanadian brandsDINsMarketedSourceable
TheophyllineAA-THEO LA · APO-THEO ER · ELIXIR DE THEOPHYLLINE · PMS-THEOPHYLLINE ELIXIR · +27 more396Yes
Theophylline, Combinations Excl. PsycholepticsBRONCHYL SYR · CHOLEDYL EXPECTORANT · I D M EXPECTORANT TAB · IDM TAB · +8 more121Yes
AminophyllineAMINOPHYLLINE INJ 25MG/ML · AMINOPHYLLINE INJ 50MG/ML · AMINOPHYLLINE INJECTION 50MG/ML · AMINOPHYLLINE TAB 0.1GM · +4 more91Yes
Choline TheophyllinateAPO OXTRIPHYLLINE TAB 100MG · APO OXTRIPHYLLINE TAB 200MG · APO OXTRIPHYLLINE TAB 300MG · CHOLEDYL · +13 more170Not in Canada
DiprophyllinePROTOPHYLLINE ELIXIR 100MG · PROTOPHYLLINE INJ 500MG/2ML · PROTOPHYLLINE SOLUTION 100MG · PROTOPHYLLINE SUP 500MG ADULTES · +1 more50Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC R03D

ATC subgroupMoleculesDINsMarketed
R03DCMontelukast · Zafirlukast9841
R03DXBenralizumab · Mepolizumab · Omalizumab · Reslizumab · Roflumilast · +1 more1917
R03DBTheophylline And Adrenergics10

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database. Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 00828742. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.